April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research, Cancer Treatment
Tags:
BRCA, Ovarian Cancer, Genetic Testing, BRCA1, BRCA2, PALB2, Pancreatic Cancer, ATM, Gene Panel Testing, Metastatic Breast Cancer, Ovarian Cancer Treatment, PARP Inhibitor, Cancer Research, Advanced Breast Cancer, Inherited Mutations, Prostate Cancer Treatment, Metastatic Prostate Cancer, Cancer Targeted Therapy
February 07, 2018
Why I Chose Immunotherapy for Pancreatic Cancer
Posted in:
Men With Mutations, Cancer Treatment
Tags:
BRCA2, HBOC, Cancer Research, Immunotherapy, Immunooncology, Pancreatic Cancer Treatment
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
August 27, 2018
FORCE Co-Authors Paper on Engaging Patient Advocates in Research
May 21, 2020
Clinical Trials are Essential for Improving Healthcare
Posted in:
Research, XRAY
Tags:
Hereditary Cancer, Breast Cancer, Ovarian Cancer, HBOC, Clinical Trials, Cancer Research, Research
May 01, 2019
Where’s FORCE?
Posted in:
FORCE And FORCE Impact
Tags:
Hereditary Cancer, Cancer Advocacy, Cancer Research, Where's Force
November 19, 2019
FORCE Launches the New XRAY-Ovarian Cancer Program
Posted in:
XRAY
Tags:
Hereditary Cancer, PARP Inhibitor, Cancer Research